Actively Recruiting
Clinical Follow-up Study on Thumbtack Needle Therapy for Postoperative Sleep and Recovery after Breast Cancer Surgery
Led by The First Affiliated Hospital of Xiamen University · Updated on 2025-01-03
110
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the effects of thumb-tack needle therapy on sleep and recovery after general anesthesia in patients who have undergone breast cancer surgery. The study aims to understand how this therapy might improve sleep quality, prevent sleep disorders after surgery, and aid in recovery. The focus is on women aged 18 to 55 years with no history of chronic insomnia or recent sedative use. The trial involves patients undergoing breast cancer surgery under general anesthesia who meet specific health criteria. Participants receive thumb-tack needle therapy as part of the follow-up treatment to evaluate its impact on postoperative sleep and recovery. The study does not specify additional treatment groups or comparators. Participants will have their sleep quality assessed using the Pittsburgh Sleep Quality Index before anesthesia and on days 1, 3, and 7 after anesthesia. Researchers will monitor recovery progress and any postoperative complications or pain. The study tracks these outcomes closely to determine the clinical significance of the thumb-tack needle therapy in improving postoperative recovery and sleep.
CONDITIONS
Official Title
A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing breast cancer surgery with general anesthesia in the hospital
- American Society of Anesthesiologists (ASA) classification I-II
- Women aged 18-55 years
- No history of chronic insomnia
- Individuals who have not taken sedative-hypnotic drugs within the past month
You will not qualify if you...
- Not meeting the above inclusion criteria
- History of severe heart, brain, lung, or kidney diseases such as acute coronary syndrome, severe heart failure (NYHA Class III or IV), severe arrhythmias, severe valvular disease, acute aortic disease, or severe peripheral vascular disease
- Poor physical condition including reduced exercise tolerance, multi-organ dysfunction, or malnutrition
- History of sleep disorders or psychiatric conditions
- Inability to receive thumb-tack needle treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China, 361000
Actively Recruiting
2
First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China, 361000
Actively Recruiting
Research Team
B
Bin Yang doctor
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here